Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Are The Current (2025) And Forecast (2029) Sizes Of The Intravenous Therapy Solutions Market?
The intravenous therapy solutions market has experienced rapid expansion over recent years. It is projected to increase from $11.95 billion in 2024 to $13.17 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.3%. The market’s growth in the past can be attributed to increasing hospital admissions, a rise in surgical procedures, a growing incidence of dehydration, a higher prevalence of chronic diseases, and improving access to healthcare infrastructure.
The intravenous therapy solutions market is projected to experience substantial expansion in the coming years. This market is set to reach a size of $19.33 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.1%. Key factors driving this growth during the forecast period include an aging global population, the expansion of services in home healthcare, a heightened need for swift rehydration therapies, the increasing occurrence of gastrointestinal conditions, and the growing adoption of disposable IV components. Prominent trends anticipated over the forecast period encompass innovations in IV drug administration technologies, a movement towards receiving IV treatment at home, the incorporation of intelligent infusion devices, an increase in infusions of biologic and specialized drugs, and a growing demand for personalized IV nutrition solutions.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25802&type=smp
What Are The Top Growth Drivers Impacting The Intravenous Therapy Solutions Market Outlook?
The increasing demand for minimally invasive therapies is projected to fuel the expansion of the intravenous therapy solutions market in the future. Minimally invasive therapies are medical treatments that involve minimal incisions or insertions into the body, commonly resulting in quicker recovery and reduced complications. The heightened demand for these therapies is attributed to their capability to lessen postoperative pain, which in turn leads to faster patient recovery and improved overall comfort during the healing process. Intravenous therapy solutions support minimally invasive therapies by enabling the efficient delivery of essential fluids, medications, and nutrients directly into the bloodstream, thereby ensuring optimal patient care and accelerated recovery. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures saw a 7% increase in 2023, exceeding surgical procedures by 2%. Therefore, the growing demand for minimally invasive therapies is a primary driver for the growth of the intravenous (IV) therapy solutions market.
How Is The Intravenous Therapy Solutions Market Classified Into Different Segments?
The intravenous therapy solutions market covered in this report is segmented –
1) By Product Type: Crystalloids, Colloids, Blood Products, Other Product Types
2) By Application: Fluid And Electrolyte Imbalance, Nutritional Support, Medication Administration, Blood Transfusion, Other Applications
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Other End-Users
Subsegments:
1) By Crystalloids: Normal Saline (0.9% Sodium Chloride), Half Normal Saline (0.45% Sodium Chloride), Lactated Ringer’s Solution, Dextrose Solutions, Hypertonic Saline
2) By Colloids: Albumin, Dextran, Hydroxyethyl Starch (HES), Gelatin
3) By Blood Products: Packed Red Blood Cells (PRBCs), Platelets, Fresh Frozen Plasma (FFP), Cryoprecipitate
4) By Other Product: Intravenous Immunoglobulins (IVIG), Parenteral Nutrition Solutions, Specialty Intravenous Drugs And Additives
What Long-Term Trends Will Shape The Future Growth Of The Intravenous Therapy Solutions Industry?
Leading companies in the intravenous therapy solutions market are concentrating on developing innovative solutions, such as ready-to-use drug infusion, to improve treatment efficiency and decrease preparation time in clinical settings. Ready-to-use drug infusion refers to pre-mixed, pre-labeled intravenous (IV) medications that are prepared in standardized doses and packaging, thus eliminating the requirement for on-site compounding or dilution. For instance, in May 2024, B. Braun Medical Inc., a US-based manufacturing company, launched Levetiracetam in Sodium Chloride Injection, an intravenous anticonvulsant solution that is ready for immediate use. This product is designed for the treatment of seizures and is available in standardized concentrations and volumes, removing the need for dilution or compounding at the point of care. The Levetiracetam IV formulation comes pre-mixed in a flexible container, ensuring accuracy in dosing, reducing the risk of contamination, and enhancing convenience for healthcare professionals in emergency and inpatient settings.
Who Are The Top Performing Companies In The Intravenous Therapy Solutions Market In Recent Years?
Major companies operating in the intravenous therapy solutions market are Pfizer Inc., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy’s Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Teleflex Incorporated, Hikma Pharmaceuticals PLC, ICU Medical Inc., Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/intravenous-therapy-solutions-global-market-report
Which Region Shows The Highest Potential For Future Expansion In The Intravenous Therapy Solutions Market?
North America was the largest region in the intravenous therapy solutions market in 2024. The regions covered in the intravenous therapy solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Intravenous Therapy Solutions Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25802&type=smp
Browse Through More Reports Similar to the Global Intravenous Therapy Solutions Market 2025, By The Business Research Company
Intravenous Solutions Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report
Intravenous Iv Hydration Therapy Global Market Report 2025
Intravenous Immunoglobulin Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model